Jul 2026
Development of a Protective Cellular Therapy to Prevent Graft Versus Host Disease Post Allogenic Hematopoietic Stem Cell Transplant 2331939
Results affirm PLZF overexpression as a viable, programmable approach for GVHD prophylaxis, poised for clinical advancement and hold promise for revolutionizing allo-HSCT by decoupling immune tolerance from antitumor immunity.
Jake Cox, Dhruti Patel, Steven Montecinos Montes et al.
· Journal of Immunology · 0 citations